*Do various viruses who require intracellular multiplication
also require use of EIF4G?
*Can blocking Cap dependent transcription through the PKC delta an effective antitumor activity during maintenance therapy.
*can we afford anhilation/blocking RAFT1?
*should blocking dimerization of EIF4G an effective therapeutic intervention in Cancer
*Does limitation of activity at the RHEB limit activity of an m-TOR and B-raf inhibitor combination, or RHEB Amplification a sign of resistance or otherwise sensitivity to B-RAF inhibitor, can the RHEB be used as a Bio-marker?
*Activity of RYR1, TRDN genes in Alzheimer dementia
*Does suppression of AGAP2 a sign of hormone failure in ER positive Breast cancer?
*Could blocking SHC exacerbate or Increase Apoptosis and c-MYC amplification
No comments:
Post a Comment